Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 9 subfamily B member 2 pseudogene" (ENSG00000274167) is a nonfunctional genomic segment that closely resembles the functional SLC9B2 gene, which encodes a sodium–hydrogen antiporter; however, it lacks the ability to produce a functional protein product[2][4]. Like other pseudogenes, it is a remnant of gene duplication or retrotransposition events and is classified as a "pseudogene" because disabling mutations prevent it from fulfilling the role of its parent gene. While some pseudogenes play roles in gene regulation at the RNA level, there is no evidence that this particular pseudogene has a specific function, therapeutic relevance, or disease linkage. Modern genetics databases and nomenclature committees, such as HGNC, consider pseudogenes non-targets for drug development or clinical intervention[2][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 9 subfamily B member 2 pseudogene (SLC9B2P).